<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>PURPOSE: The prevalence of most minor cardiovascular manifestations in <z:e sem="disease" ids="C0024796" disease_type="Disease or Syndrome" abbrv="MFS|MFS1">Marfan syndrome</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MFS</z:e>) is unknown </plain></SENT>
<SENT sid="1" pm="."><plain>We assessed the prevalence of minor cardiovascular manifestations in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MFS</z:e> to evaluate their usefulness in a diagnostic setting </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: Seventy-seven patients with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MFS</z:e> (aged 4 months to 55 years) underwent echocardiography to assess the presence of <z:hpo ids='HP_0001634'>mitral valve prolapse</z:hpo> and the diameter of the main pulmonary artery </plain></SENT>
<SENT sid="3" pm="."><plain>A subset of 29 adult patients with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MFS</z:e> also underwent magnetic resonance imaging evaluation of the diameters of the thoracoabdominal aorta </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: <z:hpo ids='HP_0001634'>Mitral valve prolapse</z:hpo> was encountered in 66% of patients with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MFS</z:e>, with an equal distribution of classic and nonclassic <z:hpo ids='HP_0001634'>mitral valve prolapse</z:hpo> </plain></SENT>
<SENT sid="5" pm="."><plain>The main pulmonary artery diameter was significantly larger in patients with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MFS</z:e> at <z:hpo ids='HP_0000001'>all</z:hpo> ages when compared with controls </plain></SENT>
<SENT sid="6" pm="."><plain>In the adult group (&gt; or = 14 years), we were able to provide a cutoff value of 23 mm to define <z:hpo ids='HP_0004927'>pulmonary artery dilatation</z:hpo> </plain></SENT>
<SENT sid="7" pm="."><plain>The descending aorta was enlarged, but with substantial overlap with controls, thus precluding the use of a cutoff value </plain></SENT>
<SENT sid="8" pm="."><plain>CONCLUSIONS: <z:hpo ids='HP_0001634'>Mitral valve prolapse</z:hpo> and main <z:hpo ids='HP_0004927'>pulmonary artery dilatation</z:hpo> are common findings in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MFS</z:e> patients at <z:hpo ids='HP_0000001'>all</z:hpo> ages and are easy to assess with echocardiography </plain></SENT>
<SENT sid="9" pm="."><plain>Cutoff values to define <z:mpath ids='MPATH_66'>dilatation</z:mpath> of the descending aorta are hard to define, making them of limited value in the diagnostic evaluation </plain></SENT>
<SENT sid="10" pm="."><plain>We recommend echocardiographic evaluation of <z:hpo ids='HP_0001634'>mitral valve prolapse</z:hpo> and main pulmonary artery diameter in patients referred for cardiovascular diagnostic assessment for <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MFS</z:e> </plain></SENT>
</text></document>